A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Atara Biotherapeutics
Atara Biotherapeutics
National Institutes of Health Clinical Center (CC)
Baylor College of Medicine
Baylor College of Medicine
Baylor College of Medicine
Queensland Institute of Medical Research
Cancer Research UK